Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Capstan Therapeutics, Inc.

Capstan Therapeutics, Inc.

Stage unknownSan Diego, CABiotechnology
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
3 rounds
  1. Mar 5, 2024
    Form D equity offering · $87.5M (form d sold) · 21 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Capstan Therapeutics, Inc. filed Form D: $87,499,982 sold of $174,999,964, Biotechnology”
  2. Jun 14, 2022
    Form D equity offering · $76.5M (form d sold) · 14 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Capstan Therapeutics, Inc. filed Form D: $76,499,983 sold of $101,999,962, Biotechnology”
  3. Nov 24, 2021
    Form D equity offering · $63.0M (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Capstan Therapeutics, Inc. filed Form D: $62,999,992 sold of $62,999,992, Biotechnology”
Investors on record
2 edges
People
5 officers, 10 directors
Timeline
3
  1. Mar 20, 2024
    Capstan Therapeutics, Inc. filed Form D: $62,999,992 sold of $62,999,992, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Mar 20, 2024
    Capstan Therapeutics, Inc. filed Form D: $76,499,983 sold of $101,999,962, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Mar 20, 2024
    Capstan Therapeutics, Inc. filed Form D: $87,499,982 sold of $174,999,964, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
25 observations
Every observation on this company